Novel gene disruptions, compositions and methods relating thereto

Details for Australian Patent Application No. 2005280266 (hide)

Owner Lexicon Genetics Incorporated Genentech, Inc.

Inventors Ye, Weilan; Montgomery, Chuck; Sparks, Mary Jean; Edwards, Joel; Brennan, Jane; Vogel, Peter; Huang, Wenhu; Payne, Bobby Joe; Desauvage, Frederic; Shi, Zheng-Zheng

Agent Griffith Hack

Pub. Number AU-A-2005280266

PCT Pub. Number WO2006/026222

Priority 60/604,323 25.08.04 US

Filing date 23 August 2005

Wipo publication date 9 March 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/026222 Priority application(s): WO2006/026222

7 June 2007 Amendment Made

  The nature of the amendment is: Amend the co-inventor name from Montgomery, Chuck to Montgomery, Charles

14 June 2007 Change of Name(s) of Applicant(s), Section 104

  Genentech, Inc.; Lexicon Genetics Incorporated The name of the applicant has been changed to Genentech, Inc.; Lexicon Pharmaceuticals, Inc.

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005280270-Systems and methods of actuating MEMS display elements

2005280259-Compositions containing alpha2-adrenergic agonist components